VENOUS STENT BV

venous-stent-bv-logo

Venous Stent has developed a patented, novel, dedicated segmental venous stent with a design that allows for superior clinical outcomes as it is more flexible with higher porosity and radial force

#SimilarOrganizations #People #Financial #Website #More

VENOUS STENT BV

Industry:
Health Care Medical Medical Device

Founded:
2019-06-28

Address:
Amsterdam, Noord-Holland, The Netherlands

Country:
The Netherlands

Website Url:
http://www.venousstent.com

Total Employee:
1+

Status:
Active

Technology used in webpage:
Google Maps Font Awesome Dutch Server Location


Similar Organizations

biodgraft-logo

BioDGraft

BioDGraft is developing a novel, biodegradable graft suitable for small-diameter vessels to improve the treatment of arteriosclerosis

respiosa-logo

Respiosa

Advancing obstructive sleep apnea patients to breathe again

superseton-logo

SuperSeton

SuperSeton improves comfort and reduce complications for patients with anal fistulae

Current Employees Featured

not_available_image

Cees Wittens
Cees Wittens Inventor & CSO @ Venous Stent BV
Inventor & CSO

jeroen-kodde_image

Jeroen Kodde
Jeroen Kodde CEO @ Venous Stent BV
CEO

Investors List

nlc-accelerating-healthtech-inventions_image

NLC

NLC investment in Pre Seed Round - Venous Stent BV

Official Site Inspections

http://www.venousstent.com

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.107
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Venous Stent BV"

WStent | Home

Length adjustable multi-segmented venous stent Our technology The development of W-stent is sponsored with a grant from LIOF, the regional development agency for Limburg.See details»

Venous Stent BV - Crunchbase Company Profile

Organization. Venous Stent BV . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Worldโ€™s first โ€ฆSee details»

Venous Stent BV - VentureRadar

Venous Stent B.V. develops the worldโ€™s first in length adjustable multi-segmented venous stent: The WStent. This design is based on the fact that in venous stenting it is not necessary to โ€ฆSee details»

Venous Stent Company Profile 2025: Valuation, Funding

Venous Stent General Information Description. Developer of medical equipment designed for the treatment of deep vein thrombosis and blood clotting. The company offers innovative โ€ฆSee details»

VenoStent 2025 Company Profile: Valuation, Funding โ€ฆ

Information on valuation, funding, cap tables, investors, and executives for VenoStent. Use the PitchBook Platform to explore the full profile.See details»

WStent | Home - venous stent

Venous Stent B.V. develops the worldโ€™s first in length adjustable multi-segmented tapered venous stent: The WStent. This design is based on the fact that in venous stenting it is not necessary to cover the complete endothelial wall as in โ€ฆSee details»

Team Venous Stent

Dr. Houman Jalaie. Head European Venous Center Aachen-Maastricht. Lars Olthof, MSc. Financial Strategy. © Copyright 2025 Venous Stent B.V.See details»

VenoStent - Crunchbase Company Profile & Funding

VenoStent is a clinical-stage tissue engineering company thatโ€™s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year.See details»

VenoStent, Inc. - Company Profile

VenoStent, Inc. VenoStent is a venture backed, clinical stage medical device and tissue engineering company developing bioabsorbable wraps to transform outcomes in vascular surgerySee details»

Venous Stent - Overview, News & Similar companies - ZoomInfo

Venous Stent. Blood & Organ Banks · Netherlands · <25 Employees. View Company Info for Free. About. Headquarters Netherlands. Phone Number +31 653784755. Website โ€ฆSee details»

Venous Stents: Current Status and Future Directions - PubMed

The ideal venous stent must provide requisite flexibility, strength, and accurate deployment for the anatomical and pathophysiological conditions of chronic venous disease. Venous stent โ€ฆSee details»

Complications of Deep Venous Stenting and Their Management

A .gov website belongs to an official government organization in the United States . Secure .gov websites use HTTPS ... Shammas NW, Lichtenberg M, Mwipatayi BP, Settlage RA. Three โ€ฆSee details»

Venous Stenting - PubMed

Aug 8, 2023 Awareness in the treatment of venous disorders through the use of stents has increased over the past decade. Venous stenting is recognized as a possible treatment to help โ€ฆSee details»

Effect of Extrusion Ratio on Mechanical and in Vitro Degradation ...

2 days ago Cardiovascular diseases are responsible for 17 million deaths annually, representing one-third of all global deaths, according to the World Health Organization. 1 Stent implantation โ€ฆSee details»

Endovascular Treatment for Venous Diseases: Where are the โ€ฆ

Although endovascular treatment for venous diseases appears promising and safe,1 the inconsistency of available studies underscores the need to improve knowledge about optimal โ€ฆSee details»

Reviewing five years of deep venous stenting: What comes next?

May 10, 2018 For many venous specialists, dedicated venous stents represent the futureโ€”and the promise of an ideal venous stent on the horizon is a central topic of discussion. In this โ€ฆSee details»

Venous Stenting Procedure | Venoplasty & Venous Stenting

This compression results in fibrosis (scar tissue) in the vessel wall. The growth of the fibrosis results in the narrowing of the vein. The narrowing can be reopened using a venous stent. โ€ฆSee details»

Surveying the 2019 Venous Stent Landscape - Endovascular Today

Venous Stent Fractures. The prevalence and long-term sequelae of venous stent fractures are not yet fully understood. Because most of stents placed in the trials reported so far likely do not โ€ฆSee details»

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the โ€ฆ

Feb 27, 2025 Fondaparinux, a synthetic pentasaccharide that selectively binds antithrombin and causes rapid and predictable inhibition of Factor Xa, was evaluated in patients with high-risk โ€ฆSee details»

Venous Stents Market Size, Demand & Trends 2023-2033

Sales Analysis of Venous Stents Market from 2018 to 2022 Vs Market Outlook for 2023 to 2033. The global sales of the venous stents are anticipated to rise at a CAGR of 8.4% between 2023 โ€ฆSee details»

linkstock.net © 2022. All rights reserved